Maribavir for refractory cytomegalovirus infection (with or without resistance) in solid organ transplant recipients: subgroup analysis of the phase 3 randomized SOLSTICE study
Resource type
Journal Article
Authors/contributors
- Blumberg, Emily A. (Author)
- Witzke, Oliver (Author)
- Mbbs, Mark Harber (Author)
- Ison, Michael G. (Author)
- Saliba, Faouzi (Author)
- Kamar, Nassim (Author)
- Sundberg, Aimee K. (Author)
- Gu, Joan (Author)
- Kumar, Deepali (Author)
- La Hoz, Ricardo M. (Author)
Title
Maribavir for refractory cytomegalovirus infection (with or without resistance) in solid organ transplant recipients: subgroup analysis of the phase 3 randomized SOLSTICE study
Publication
The Journal of Heart and Lung Transplantation
Date
11/2024
Pages
S1053249824019715
Journal Abbr
The Journal of Heart and Lung Transplantation
Accessed
12/5/24, 11:39 PM
ISSN
10532498
Short Title
Maribavir for refractory cytomegalovirus infection (with or without resistance) in solid organ transplant recipients
Language
en
Library Catalog
DOI.org (Crossref)
Citation
Blumberg, E. A., Witzke, O., Mbbs, M. H., Ison, M. G., Saliba, F., Kamar, N., Sundberg, A. K., Gu, J., Kumar, D., & La Hoz, R. M. (2024). Maribavir for refractory cytomegalovirus infection (with or without resistance) in solid organ transplant recipients: subgroup analysis of the phase 3 randomized SOLSTICE study. The Journal of Heart and Lung Transplantation, S1053249824019715. https://doi.org/10.1016/j.healun.2024.11.026
Link to this record